<DOC>
	<DOC>NCT00083954</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy of quetiapine compared to placebo in the treatment for a major depressive episode in patients with bipolar disorder after receiving treatment for up to 8 weeks.</brief_summary>
	<brief_title>Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision of informed consent before enrollment and any studyspecific procedures. Patients deemed incapable of providing written consent will not be enrolled in this study; outpatient status More than 8 mood episodes in the past year from screen (visit 1); A current Axis I disorder other than bipolar disorder within 6 months of screening; patients with clinically significant abnormal laboratory findings in the investigator's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>